Search PDMR transactions

Notifier
Name of person with notification obligation
Hangethe Consulting AB
Reason for notification
Closely associated
Yes
Person discharging managerial responsibilities
Patrik Fagerholm
Position
Chief Financial Officer (CFO)
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
NextCell Pharma AB
Issuer´s LEI code
549300PBFGB5JYKXGA45
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share NextCell Pharma AB SE0009723125 Disposal 217,389 Quantity 0.9916 SEK 13/06/2025 FIRST NORTH SWEDEN
Share NextCell Pharma AB SE0009723125 Acquisition 218,389 Quantity 1.0165 SEK 13/06/2025 FIRST NORTH SWEDEN
Share NextCell Pharma AB SE0009723125 Disposal 199,891 Quantity 0.9849 SEK 16/06/2025 FIRST NORTH SWEDEN
Share NextCell Pharma AB SE0009723125 Acquisition 198,891 Quantity 0.9939 SEK 16/06/2025 FIRST NORTH SWEDEN
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
NextCell Pharma AB SE0009723125 Disposal 13/06/2025 FIRST NORTH SWEDEN 217,389 (Quantity) 0.9916 SEK
NextCell Pharma AB SE0009723125 Acquisition 13/06/2025 FIRST NORTH SWEDEN 218,389 (Quantity) 1.0165 SEK
NextCell Pharma AB SE0009723125 Disposal 16/06/2025 FIRST NORTH SWEDEN 199,891 (Quantity) 0.9849 SEK
NextCell Pharma AB SE0009723125 Acquisition 16/06/2025 FIRST NORTH SWEDEN 198,891 (Quantity) 0.9939 SEK
<< Back